menu

Progression of SHPT in Patients with CKD and the Benefits and Drawbacks of Vitamin D Therapies

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Progression of SHPT in Patients with CKD and the Benefits and Drawbacks of Vitamin D Therapies

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    Vitamin D insufficiency is prevalent in patients with chronic kidney disease (CKD) and is a driver of secondary hyperparathyroidism (SHPT). This deficiency is also an important factor in chronic kidney disease-mineral and bone disorder (CKD-MBD), which encompasses mineral, bone, and calcific cardiovascular abnormalities. This animation illustrates the progression of SHPT in patients with CKD as well as the benefits and drawbacks of the various vitamin D forms that are available to restore 25-OH vitamin D levels in patients with stages 3 and 4 non-dialysis CKD. 

Facebook Comments

Recommended
Details
Comments
  • Overview

    Vitamin D insufficiency is prevalent in patients with chronic kidney disease (CKD) and is a driver of secondary hyperparathyroidism (SHPT). This deficiency is also an important factor in chronic kidney disease-mineral and bone disorder (CKD-MBD), which encompasses mineral, bone, and calcific cardiovascular abnormalities. This animation illustrates the progression of SHPT in patients with CKD as well as the benefits and drawbacks of the various vitamin D forms that are available to restore 25-OH vitamin D levels in patients with stages 3 and 4 non-dialysis CKD. 

Facebook Comments

Schedule23 Feb 2024